+987.9%
MRNA vs SSNC
-3.9%
+991.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SSNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -1.6% | +14.7% | +14.0% |
| 7D | +20.6% | -1.1% | +21.8% | +21.2% |
| 30D | +27.1% | +0.6% | +26.5% | +25.0% |
| 3M | +353.4% | -1.5% | +354.9% | +352.9% |
| 6M | +446.3% | +15.8% | +430.4% | +432.8% |
| YTD | +776.2% | -8.0% | +784.1% | +808.3% |
| 1Y | +987.9% | -5.8% | +993.7% | +1,013.1% |
| All | +987.9% | -3.9% | +991.9% | +1,013.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SSNC.
Daily Out/Under-Performance
Portfolio return minus SSNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SSNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SSNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling